IFNB1 and myeloid sarcoma: For example, a study conducted in British Columbia, Canada, showed that exposure to beta-interferon (versus no exposure) was not associated with a lower hazard of reaching an Expanded Disability Status Scale [EDSS] score of 6 in older MS adults, aged≥50 years (44).